tiprankstipranks
Trending News
More News >
Nova Leap Health Corp (TSE:NLH)
:NLH
Canadian Market

Nova Leap Health (NLH) Ratios

Compare
11 Followers

Nova Leap Health Ratios

TSE:NLH's free cash flow for Q4 2024 was $0.39. For the 2024 fiscal year, TSE:NLH's free cash flow was decreased by $ and operating cash flow was $0.17. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.00 1.59 1.00 0.96 1.04
Quick Ratio
1.00 1.59 1.00 0.96 1.04
Cash Ratio
0.32 0.50 0.32 0.28 0.67
Solvency Ratio
0.10 -0.19 0.10 0.32 0.23
Operating Cash Flow Ratio
0.26 1.21 0.26 0.35 0.72
Short-Term Operating Cash Flow Coverage
0.43 10.35 0.43 0.55 1.10
Net Current Asset Value
$ -1.29M$ 142.17K$ -1.29M$ -2.33M$ -3.36M
Leverage Ratios
Debt-to-Assets Ratio
0.17 0.07 0.17 0.23 0.34
Debt-to-Equity Ratio
0.21 0.08 0.21 0.34 0.61
Debt-to-Capital Ratio
0.18 0.07 0.18 0.25 0.38
Long-Term Debt-to-Capital Ratio
<0.01 0.00 <0.01 0.05 0.22
Financial Leverage Ratio
1.28 1.15 1.28 1.45 1.78
Debt Service Coverage Ratio
0.30 3.70 0.30 0.92 1.09
Interest Coverage Ratio
-4.06 3.18 -4.06 9.71 4.05
Debt to Market Cap
0.17 0.01 0.17 0.14 0.15
Interest Debt Per Share
0.05 0.02 0.05 0.09 0.10
Net Debt to EBITDA
6.41 0.51 6.41 0.94 1.35
Profitability Margins
Gross Profit Margin
35.37%37.31%35.37%33.89%33.92%
EBIT Margin
-3.32%1.76%-3.32%13.51%3.31%
EBITDA Margin
1.49%3.80%1.49%22.35%13.63%
Operating Profit Margin
-3.90%1.76%-3.90%18.30%10.48%
Pretax Profit Margin
-4.28%-5.22%-4.28%11.62%0.73%
Net Profit Margin
-2.96%-4.03%-2.96%8.27%7.26%
Continuous Operations Profit Margin
-2.96%-4.03%-2.96%8.27%7.26%
Net Income Per EBT
69.27%77.21%69.27%71.19%1000.90%
EBT Per EBIT
109.73%-296.86%109.73%63.52%6.92%
Return on Assets (ROA)
-3.49%-5.05%-3.49%6.58%7.16%
Return on Equity (ROE)
-4.47%-5.80%-4.47%9.53%12.76%
Return on Capital Employed (ROCE)
-5.51%2.41%-5.51%18.95%13.58%
Return on Invested Capital (ROIC)
-3.36%1.81%-3.36%11.17%111.82%
Return on Tangible Assets
-12.26%-18.40%-12.26%22.05%20.91%
Earnings Yield
-5.84%-6.01%-5.84%4.91%3.28%
Efficiency Ratios
Receivables Turnover
16.09 15.85 16.09 9.80 12.30
Payables Turnover
15.56 13.95 15.56 13.98 12.09
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
18.88 22.03 18.88 16.45 43.79
Asset Turnover
1.18 1.25 1.18 0.79 0.99
Working Capital Turnover Ratio
-205.24 50.06 -205.24 -406.90 -31.68
Cash Conversion Cycle
-0.77 -3.13 -0.77 11.13 -0.51
Days of Sales Outstanding
22.69 23.03 22.69 37.23 29.68
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
23.46 26.16 23.46 26.10 30.19
Operating Cycle
22.69 23.03 22.69 37.23 29.68
Cash Flow Ratios
Operating Cash Flow Per Share
0.01 0.02 0.01 0.03 0.05
Free Cash Flow Per Share
0.01 0.02 0.01 0.03 0.05
CapEx Per Share
<0.01 <0.01 <0.01 0.00 <0.01
Free Cash Flow to Operating Cash Flow
0.93 0.99 0.93 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
14.33 76.98 14.33 0.00 448.33
Capital Expenditure Coverage Ratio
14.33 76.98 14.33 0.00 448.33
Operating Cash Flow Coverage Ratio
0.26 1.54 0.26 0.35 0.51
Operating Cash Flow to Sales Ratio
0.04 0.08 0.04 0.10 0.17
Free Cash Flow Yield
6.63%12.12%6.63%6.08%7.84%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-17.14 -16.64 -17.14 20.38 30.51
Price-to-Sales (P/S) Ratio
0.51 0.67 0.51 1.69 2.21
Price-to-Book (P/B) Ratio
0.77 0.96 0.77 1.94 3.89
Price-to-Free Cash Flow (P/FCF) Ratio
15.08 8.25 15.08 16.46 12.75
Price-to-Operating Cash Flow Ratio
14.03 8.15 14.03 16.46 12.72
Price-to-Earnings Growth (PEG) Ratio
0.11 -1.28 0.11 0.00 -0.14
Price-to-Fair Value
0.77 0.96 0.77 1.94 3.89
Enterprise Value Multiple
40.48 18.15 40.48 8.49 17.60
Enterprise Value
17.02M 18.05M 17.02M 40.35M 41.51M
EV to EBITDA
40.48 18.15 40.48 8.49 17.60
EV to Sales
0.60 0.69 0.60 1.90 2.40
EV to Free Cash Flow
17.92 8.49 17.92 18.51 13.81
EV to Operating Cash Flow
16.67 8.38 16.67 18.51 13.78
Tangible Book Value Per Share
0.02 0.04 0.02 >-0.01 -0.03
Shareholders’ Equity Per Share
0.24 0.21 0.24 0.25 0.15
Tax and Other Ratios
Effective Tax Rate
0.31 0.23 0.31 0.29 -9.01
Revenue Per Share
0.36 0.30 0.36 0.29 0.27
Net Income Per Share
-0.01 -0.01 -0.01 0.02 0.02
Tax Burden
0.69 0.77 0.69 0.71 10.01
Interest Burden
1.29 -2.97 1.29 0.86 0.22
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
0.34 0.32 0.34 0.36 0.33
Stock-Based Compensation to Revenue
0.01 <0.01 0.01 0.02 0.02
Income Quality
-1.22 -2.04 -1.22 1.24 2.40
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis